MAM
Indians want government to support Transgender People: Ipsos Global Survey
MUMBAI: Ipsos global survey onTransgender Peopleshows that a whopping 80 per cent of Indians polled want government to support and protect Transgender People from discrimination.
Interestingly, across all the 27 markets covered in the survey, more number of people agree that Transgender People should be supported and protected from social ostracism. Globally, India is placed sixth in voicing its concern for Transgender People, preceded by the top five markets of Argentina, Chile, Mexico, Ecuador and Great Britain.
Government support and social acceptance will mitigate discrimination and help Transgender People lead a more dignified life,” says Parijat Chakraborty, Executive Director, Ipsos Public Affairs.
As part of Ipsos’ ongoing commitment to bringing voice to people through data, Ipsos undertook a survey on the topic of transgender people using the monthly global survey vehicle Global Advisor. The data was collected online between October 24th and November 7th, 2017.
The 27 markets covered in the survey were: Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Ecuador, France, Great Britain, Germany, Hungary, India, Italy, Japan, Malaysia, Mexico, Peru, Poland, Russia, Serbia, South Africa, South Korea, Spain, Sweden, Turkey, and the United States of America.
Given the range of (mis)perceptions that exist about transgender people, Ipsos and BuzzFeed, in discussion with the Williams Institute, developed a series of questions in 2016 designed to better understand how people perceive and understand the concept and emergence of transgender individuals.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
